NO932101L - Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker - Google Patents

Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker

Info

Publication number
NO932101L
NO932101L NO93932101A NO932101A NO932101L NO 932101 L NO932101 L NO 932101L NO 93932101 A NO93932101 A NO 93932101A NO 932101 A NO932101 A NO 932101A NO 932101 L NO932101 L NO 932101L
Authority
NO
Norway
Prior art keywords
humans
administered
substances
polypeptid
material used
Prior art date
Application number
NO93932101A
Other languages
English (en)
Other versions
NO308396B1 (no
NO932101D0 (no
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO932101D0 publication Critical patent/NO932101D0/no
Publication of NO932101L publication Critical patent/NO932101L/no
Publication of NO308396B1 publication Critical patent/NO308396B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932101A 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur NO308396B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy

Publications (3)

Publication Number Publication Date
NO932101D0 NO932101D0 (no) 1993-06-09
NO932101L true NO932101L (no) 1993-08-10
NO308396B1 NO308396B1 (no) 2000-09-11

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932101A NO308396B1 (no) 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Country Status (16)

Country Link
US (1) US5824640A (no)
EP (1) EP0574394B1 (no)
JP (1) JP3213942B2 (no)
KR (1) KR100196028B1 (no)
AT (1) ATE122890T1 (no)
AU (1) AU661287B2 (no)
CA (1) CA2098113C (no)
CZ (1) CZ283037B6 (no)
DE (1) DE69110060T2 (no)
DK (1) DK0574394T3 (no)
ES (1) ES2073277T3 (no)
HU (1) HU217615B (no)
IT (1) IT1244879B (no)
NO (1) NO308396B1 (no)
RU (1) RU2113224C1 (no)
WO (1) WO1992010197A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
NZ334714A (en) 1996-09-18 2000-08-25 Zetesis Spa Liver proteins as agents against autoimmune diseases
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
AU2001278436A1 (en) * 2000-06-08 2001-12-17 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
MXPA02012092A (es) * 2000-06-08 2004-08-19 Rakepoll Holding B V Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
RU2211700C2 (ru) * 2001-07-23 2003-09-10 Научно-исследовательский институт медико-биологических проблем Республики Северная Осетия-Алания Способ получения лекарственного препарата "скваакан"
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.
RU2390353C2 (ru) * 2004-02-12 2010-05-27 Мерк Патент Гмбх Высококонцентрированные жидкие композиции анти-egfr антител
RU2292393C2 (ru) * 2005-03-03 2007-01-27 Закрытое акционерное общество "Научно-производственное предприятие "Тринита" Способ получения ингибитора коллагеназы из гепатопанкреаса промысловых видов краба

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
WO1985003003A1 (fr) * 1984-01-12 1985-07-18 Volker Rusch Substance biologiquement active avec des proprietes hormonales, son procede de fabrication et utilisation d'histones a des fins medicales
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
KR100196028B1 (ko) 1999-06-15
NO308396B1 (no) 2000-09-11
RU2113224C1 (ru) 1998-06-20
WO1992010197A1 (en) 1992-06-25
AU9035791A (en) 1992-07-08
CZ283037B6 (cs) 1997-12-17
JP3213942B2 (ja) 2001-10-02
HUT64569A (en) 1994-01-28
IT9022341A1 (it) 1992-06-11
JPH06504039A (ja) 1994-05-12
EP0574394B1 (en) 1995-05-24
ES2073277T3 (es) 1995-08-01
US5824640A (en) 1998-10-20
ATE122890T1 (de) 1995-06-15
CA2098113C (en) 2002-02-05
IT1244879B (it) 1994-09-12
HU9301677D0 (en) 1993-09-28
HU217615B (hu) 2000-03-28
CA2098113A1 (en) 1992-06-11
CZ111693A3 (en) 1994-04-13
NO932101D0 (no) 1993-06-09
EP0574394A1 (en) 1993-12-22
DK0574394T3 (da) 1995-10-16
DE69110060D1 (de) 1995-06-29
DE69110060T2 (de) 1995-09-28
AU661287B2 (en) 1995-07-20
IT9022341A0 (it) 1990-12-11

Similar Documents

Publication Publication Date Title
NO932101D0 (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
DE69807349D1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
EP0719150A4 (en) CELLULAR VACCINE AND METHODS OF USE FOR TREATING MALIGNAS, SOLID TUMORS
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
DE3789082D1 (de) Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors.
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
ES2187568T3 (es) Vacuna viva para el tratamiento de enfermedades tumorales.
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE187493T1 (de) Gp75 als tumorimpfstoff gegen melanome
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
ES8704082A1 (es) Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.
EP0716614A4 (en) TREATMENT OF HUMAN TUMORS BY GENETIC TRANSFORMATION OF HUMAN TUMORS
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
EP0136093A3 (en) Anti-cancer factors
SU1077090A1 (ru) Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека
DK0455769T3 (da) Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker
ATE65027T1 (de) Behandlung von parasiterkrankungen.
DE68911305D1 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.
Macher et al. Melanoma: Clinical and Therapeutic Aspects

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees